Obinutuzumab for relapsed or refractory indolent non-Hodgkin’s lymphomas

nork Gabellier, Ludovic, Cartron, Guillaume
Argitaratua izan da Ther Adv Hematol (2016)

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

nork Houot, Roch, Levy, Ronald, Cartron, Guillaume, Armand, Philippe
Argitaratua izan da Eur J Cancer (2020)

EZH2 in normal hematopoiesis and hematological malignancies

nork Herviou, Laurie, Cavalli, Giacomo, Cartron, Guillaume, Klein, Bernard, Moreaux, Jérôme
Argitaratua izan da Oncotarget (2015)

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

nork Gabellier, Ludovic, Bret, Caroline, Bossis, Guillaume, Cartron, Guillaume, Moreaux, Jérôme
Argitaratua izan da Cancers (Basel) (2020)

Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma

nork Ternant, David, Hénin, Emilie, Cartron, Guillaume, Tod, Michel, Paintaud, Gilles, Girard, Pascal
Argitaratua 2009

Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma

nork Ternant, David, Cartron, Guillaume, Hénin, Emilie, Tod, Michel, Girard, Pascal, Paintaud, Gilles
Argitaratua 2012

Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function

nork Vo, Dang-Nghiem, Constantinides, Michael, Allende-Vega, Nerea, Alexia, Catherine, Cartron, Guillaume, Villalba, Martin
Argitaratua izan da Vaccines (Basel) (2020)

An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy

nork Szablewski, Vanessa, Bret, Caroline, Kassambara, Alboukadel, Devin, Julie, Cartron, Guillaume, Costes-Martineau, Valérie, Moreaux, Jérôme
Argitaratua izan da Oncotarget (2018)

C-Reactive Protein Level: A Key Predictive Marker of Cachexia in Lymphoma and Myeloma Patients

nork Mallard, Joris, Gagez, Anne-Laure, Baudinet, Cedric, Herbinet, Aline, Maury, Jonathan, Bernard, Pierre Louis, Cartron, Guillaume
Argitaratua izan da J Hematol (2019)

Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies

nork Gâtel, Pierre, Brockly, Frédérique, Reynes, Christelle, Pastore, Manuela, Hicheri, Yosr, Cartron, Guillaume, Piechaczyk, Marc, Bossis, Guillaume
Argitaratua izan da Life Sci Alliance (2020)

Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma

nork Cartron, Guillaume, Hourcade-Potelleret, Florence, Morschhauser, Franck, Salles, Gilles, Wenger, Michael, Truppel-Hartmann, Anna, Carlile, David J.
Argitaratua izan da Haematologica (2016)

Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study

nork Cartron, Guillaume, Zhao-Yang, Lu, Baudard, Marion, Kanouni, Tarik, Rouillé, Valérie, Quittet, Philippe, Klein, Bernard, Rossi, Jean-Francois
Argitaratua 2008

High ratio of interfollicular CD8/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma

nork SAIFI, MAJDA, MARAN, AURÉLIE, RAYNAUD, PIERRE, PICOT, MARIE CHRISTINE, QUITTET, PHILIPPE, CARTRON, GUILLAUME, ROSSI, JEAN FRANÇOIS, COSTES, VALÉRIE
Argitaratua 2010

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton’s tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)

nork Rule, Simon A., Cartron, Guillaume, Fegan, Christopher, Morschhauser, Franck, Han, Lingling, Mitra, Siddhartha, Salles, Gilles, Dyer, Martin J. S.
Argitaratua izan da Leukemia (2019)

Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia

nork Lapierre, Marion, Castet-Nicolas, Audrey, Gitenay, Delphine, Jalaguier, Stéphan, Teyssier, Catherine, Bret, Caroline, Cartron, Guillaume, Moreaux, Jérôme, Cavaillès, Vincent
Argitaratua izan da J Hematol Oncol (2015)

Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis

nork Duroux-Richard, Isabelle, Pers, Yves-Marie, Fabre, Sylvie, Ammari, Meryem, Baeten, Dominique, Cartron, Guillaume, Touitou, Isabelle, Jorgensen, Christian, Apparailly, Florence
Argitaratua 2014

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma

nork Hassen, Wafa, Kassambara, Alboukadel, Reme, Thierry, Sahota, Surinder, Seckinger, Anja, Vincent, Laure, Cartron, Guillaume, Moreaux, Jérôme, Hose, Dirk, Klein, Bernard
Argitaratua izan da Oncotarget (2014)

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment

nork Vo, Dang-Nghiem, Alexia, Catherine, Allende-Vega, Nerea, Morschhauser, Franck, Houot, Roch, Menard, Cedric, Tarte, Karin, Cartron, Guillaume, Villalba, Martin
Argitaratua izan da Oncoimmunology (2017)

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

nork Gourzones, Claire, Bellanger, Céline, Lamure, Sylvain, Gadacha, Ouissem Karmous, De Paco, Elvira Garcia, Vincent, Laure, Cartron, Guillaume, Klein, Bernard, Moreaux, Jérôme
Argitaratua izan da Cancers (Basel) (2019)

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

nork Morschhauser, Franck, Salles, Gilles, Le Gouill, Steven, Tilly, Herve, Thieblemont, Catherine, Bouabdallah, Krimo, Fabiani, Bettina, Ménard, Cédric, Tarte, Karin, Cartron, Guillaume, Houot, Roch
Argitaratua izan da Blood (2018)